Advanced Optics Electronics Confirms Biomoda, Inc. NASD Processing; Court Orders Helping ADOT Shareholders to Stamp out Illegal Internet Postings.Business Editors ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Jan. 6, 2004 Advanced Optics Electronics, Inc. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB:ADOT ADOT Arizona Department Of Transportation ADOT Alaska Department of Transportation ADOT Fédération des Associations pour le Don d'Organes et de Tissus Humains ADOT Active Duty Other Than Training ADOT Automatic Digital Optical Tracker ADOT Advanced Display Optimization Tools ) today confirmed that NASD NASD See: National Association of Securities Dealers NASD See National Association of Securities Dealers (NASD). processing of Biomoda, Inc.'s initial public sales (Biomoda, Inc. is 30% held directly and indirectly by ADOT) is nearing completion in conjunction with the Company's securities counsel in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. . The Company further confirmed that it is near contract with several independent marketing groups for sales and licensing of its proprietary displays and display technology. Significant progress has been achieved in outdoor display marketing with interest developing in purchasing capital equipment by end users. In an effort to assist shareholders who have been harmed with recent extremely libelous In the nature of a written Defamation ,a communication that tends to injure reputation. and foul language postings on various internet sites, legal counsel for the Company in conjunction with several law firms has initiated a very aggressive and comprehensive program of tracking down this criminal activity and initiated several complaints (lawsuits) to date. Operators of various Internet venues, including Lycos, operator of "Raging Bull" have provided prompt compliance and complete cooperation with Court orders and subpoenas aimed at stamping out this illegal practice. Biomoda, Inc. plans to release several significant development announcements in the next few weeks regarding joint ventures and collaborative research efforts with far ranging effects. Advanced Optics Electronics, Inc. (ADOT - OTC: BB) is a technology company based in Albuquerque, New Mexico “Albuquerque” redirects here. For other uses, see Albuquerque (disambiguation). Albuquerque (pronounced [ˈæl.bə.kɚ.kiː], Spanish: [al.βu. . The company maintains an R&D facility and manufacturing plant, and is engaged in building large-scale flat panel displays utilizing its patented and patent pending technology. In addition to the core business of ADOT, the company has made a strategic technology oriented investment in BIOMODA, Inc. BIOMODA, Inc. is a company that holds patents and patents pending domestically and internationally for the early detection of Lung Cancer lung cancer, cancer that originates in the tissues of the lungs. Lung cancer is the leading cause of cancer death in the United States in both men and women. Like other cancers, lung cancer occurs after repeated insults to the genetic material of the cell. . ADOT currently holds directly and indirectly 30% of BIOMODA, Inc. This news release contains forward-looking statements that involve a high degree of risk and uncertainty. Such statements include, but are not limited to, statements containing the words "believes," "anticipates," "expects," "estimates," and words of similar import. The Company's actual results could differ materially from any forward-looking statements, which reflect management's opinions only as of the date of this report, as a result of risks and uncertainties that exist in our operation, development efforts and business environment. The Company undertakes no obligation to revise or publicly release the results of any revisions to these forward-looking statements. You should carefully review the risk factors in other documents that the Company files from time to time with the Securities and Exchange Commission, including its Quarterly Reports on Form 10-Q Form 10-Q See 10-Q. . |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion